Price T Rowe Associates Inc Iveric Bio, Inc. Transaction History

Price T Rowe Associates Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $177 Million - $267 Million	-6,737,387 Reduced 98.9%	75,259 $2.96 Million
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $36.8 Million - $48.4 Million	1,968,987 Added 40.65%	6,812,646 $166 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $24.1 Million - $33.5 Million	1,397,305 Added 40.54%	4,843,659 $104 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $528,411 - $1.05 Million	56,214 Added 1.66%	3,446,354 $61.8 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $11.1 Million - $23.1 Million	-1,220,136 Reduced 26.47%	3,390,140 $32.6 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $5.3 Million - $7.34 Million	-436,011 Reduced 8.64%	4,610,276 $77.6 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $925,074 - $1.26 Million	66,889 Added 1.34%	5,046,287 $84.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $20.7 Million - $51.2 Million	2,926,658 Added 142.57%	4,979,398 $80.9 Million
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $628,471 - $791,940	-110,452 Reduced 5.11%	2,052,740 $13 Million
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $48,361 - $65,592	9,520 Added 0.44%	2,163,192 $13.4 Million
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $12.2 Million - $16.5 Million	2,153,672 New	2,153,672 $14.9 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.